| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Clinical Cancer Research, Vol 1, Issue 10 1209-1215, Copyright © 1995 by American Association for Cancer Research
ARTICLES |
O Kocher, P Cheresh, LF Brown and SW Lee
Departments of Pathology and Medicine, Beth Israel Hospital and Harvard Medical School, Boston, Massachusetts 02215, USA.
Using the differential display technique, selecting for genes up-regulated in renal cell carcinoma compared with normal renal parenchyma, we isolated a novel gene, designated DD96. As determined by in situ and Northern blot hybridization studies, DD96 is expressed only in rare normal epithelial cell populations, such as the proximal tubular epithelial cells of the kidney. However, it is expressed diffusely in malignant epithelial cells of the wide majority of renal cell carcinomas. In addition, DD96 is overexpressed markedly in various human carcinomas originating from the colon, breast, and lung, as well as in a number of cell lines derived from tumors of these organs compared with normal epithelial cell populations. Furthermore, the expression of DD96 is induced in immortalized breast ductal epithelial cell lines compared with normal breast ductal epithelial cells, and, in vivo, in premalignant conditions, such as adenoma of the colon and ductal carcinoma in situ of the breast. Sequence analysis of a complete cDNA clone isolated from a human kidney cDNA library revealed that DD96 encodes for a protein of approximately Mr 13,500. These results suggest that DD96 may play a role in the early events associated with malignant transformation; however, its function remains to be determined.
This article has been cited by other articles:
|
|
 |
|
  D. J. Sugarbaker, W. G. Richards, G. J. Gordon, L. Dong, A. De Rienzo, G. Maulik, J. N. Glickman, L. R. Chirieac, M.-L. Hartman, B. E. Taillon, et al. Transcriptome sequencing of malignant pleural mesothelioma tumors PNAS, March 4, 2008; 105(9): 3521 - 3526. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. V. Guijarro, W. Link, A. Rosado, J. F.M. Leal, and A. Carnero MAP17 inhibits Myc-induced apoptosis through PI3K/AKT pathway activation Carcinogenesis, December 1, 2007; 28(12): 2443 - 2450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. V. Guijarro, J. F.M. Leal, C. Blanco-Aparicio, S. Alonso, J. Fominaya, M. Lleonart, J. Castellvi, S. Ramon y Cajal, and A. Carnero MAP17 enhances the malignant behavior of tumor cells through ROS increase Carcinogenesis, October 1, 2007; 28(10): 2096 - 2104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. V. Guijarro, J. F.M. Leal, J. Fominaya, C. Blanco-Aparicio, S. Alonso, M. Lleonart, J. Castellvi, L. Ruiz, S. Ramon y Cajal, and A. Carnero MAP17 overexpression is a common characteristic of carcinomas Carcinogenesis, August 1, 2007; 28(8): 1646 - 1652. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Lanaspa, H. Giral, S. Y. Breusegem, N. Halaihel, G. Baile, J. Catalan, J. A. Carrodeguas, N. P. Barry, M. Levi, and V. Sorribas Interaction of MAP17 with NHERF3/4 induces translocation of the renal Na/Pi IIa transporter to the trans-Golgi Am J Physiol Renal Physiol, January 1, 2007; 292(1): F230 - F242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kato, Y. Sai, K. Yoshida, C. Watanabe, T. Hirata, and A. Tsuji PDZK1 Directly Regulates the Function of Organic Cation/Carnitine Transporter OCTN2 Mol. Pharmacol., March 1, 2005; 67(3): 734 - 743. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Kocher, A. Yesilaltay, C. Cirovic, R. Pal, A. Rigotti, and M. Krieger Targeted Disruption of the PDZK1 Gene in Mice Causes Tissue-specific Depletion of the High Density Lipoprotein Receptor Scavenger Receptor Class B Type I and Altered Lipoprotein Metabolism J. Biol. Chem., December 26, 2003; 278(52): 52820 - 52825. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. L. Trigatti, M. Krieger, and A. Rigotti Influence of the HDL Receptor SR-BI on Lipoprotein Metabolism and Atherosclerosis Arterioscler. Thromb. Vasc. Biol., October 1, 2003; 23(10): 1732 - 1738. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Pribanic, S. M. Gisler, D. Bacic, C. Madjdpour, N. Hernando, V. Sorribas, A. Gantenbein, J. Biber, and H. Murer Interactions of MAP17 with the NaPi-IIa/PDZK1 protein complex in renal proximal tubular cells Am J Physiol Renal Physiol, October 1, 2003; 285(4): F784 - F791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Blasco, J. J. Aramayona, A. I. Alcalde, J. Catalan, M. Sarasa, and V. Sorribas Rat kidney MAP17 induces cotransport of Na-mannose and Na-glucose in Xenopus laevis oocytes Am J Physiol Renal Physiol, October 1, 2003; 285(4): F799 - F810. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Silver, N. Wang, and S. Vogel Identification of Small PDZK1-associated Protein, DD96/MAP17, as a Regulator of PDZK1 and Plasma High Density Lipoprotein Levels J. Biol. Chem., August 1, 2003; 278(31): 28528 - 28532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Kocher, R. Pal, M. Roberts, C. Cirovic, and A. Gilchrist Targeted Disruption of the PDZK1 Gene by Homologous Recombination Mol. Cell. Biol., February 15, 2003; 23(4): 1175 - 1180. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
